DanGer Shock‐like profile predicts the outcome in ST‐elevation myocardial infarction‐related cardiogenic shock
Abstract Aims The DanGer Shock (DGS) trial demonstrated that the routine use of a microaxial flow pump (mAFP) with standard care to treat STEMI‐related cardiogenic shock (STEMI‐CS) led to a lower risk of all‐cause death at 180 days than standard care alone. We investigated the impact of patient elig...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.15269 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|